Lysergic acid 3-pentylamide (LSP), also known as N-(3-pentyl)lysergamide, is an analogue of LSD originally researched by David E. Nichols and colleagues at Purdue University. It has similar binding affinity to LSD itself as both a 5-HT1A and 5-HT2A agonist, and produces similar behavioral and physiological responses in animals with only slightly lower potency than LSD. Other isomers of this compound have also been explored, with the 1-pentylamide being around 75% the potency of LSD, while the (R)-2-pentylamide shows similar 5-HT2A binding affinity to LSD in vitro but has only around half the potency of LSD in producing drug-appropriate responding in mice, and the (S)-2-pentylamide is inactive.
See also Substituted lysergamide Cepentil Lysergic acid 2-butylamide (LSB) Lysergic acid 2-pentylamide (2-LSP) MiPLA Methylergometrine
References
External links LSP - Isomer Design